Literature DB >> 3050690

Inflammatory diseases of the peripheral cornea.

B J Mondino1.   

Abstract

Immunologic differences exist between the peripheral and central cornea. The peripheral cornea is closer to the conjunctiva, which has all of the immunologic machinery necessary to generate an immune response. The peripheral cornea has more Langerhans' cells and IgM than the central cornea. The peripheral cornea also has more C1, the recognition unit of the classic pathway of complement, than the central cornea so that antigen-antibody complexes, whether formed in the cornea itself or whether derived from the tears, aqueous humor, or limbal vessels, may activate complement more effectively in the peripheral than central cornea. Autoimmune diseases that involve the peripheral cornea include Mooren's ulcer and collagen vascular diseases. The humoral- and cell-mediated autoimmune phenomena that are associated with Mooren's ulcer and its response to immunosuppressive therapy suggest that it is an autoimmune disease directed against the cornea itself. Collagen vascular diseases may be associated with peripheral corneal ulcers with or without scleritis. In these diseases, circulating immune complexes may lodge in the limbal vasculature causing an immune vasculitis or deposit in the peripheral cornea setting off the complement cascade. Peripheral corneal diseases that probably represent a hypersensitivity reaction to exogenous antigens include catarrhal infiltrates and ulcers and phlyctenules. In the United States today, these corneal lesions are generally associated with staphylococcal blepharitis. Experimental models suggest that hypersensitivity to Staphylococcus aureus cell wall antigens may be important to their immunopathogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050690     DOI: 10.1016/s0161-6420(88)33164-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  29 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Bilateral Mooren's ulcer in a child secondary to helminthic infestation of the gastrointestinal tract.

Authors:  Prakashchand Agarwal; Digvijay Singh; Gautam Sinha; Namrata Sharma; Jeewan Singh Titiyal
Journal:  Int Ophthalmol       Date:  2012-06-03       Impact factor: 2.031

3.  Bilateral Mooren's ulcer in six patients: diagnosis, surgery and histopathology.

Authors:  Christos D Kalogeropoulos; Vassiliki D Malamou-Mitsi; Miltiadis B Aspiotis; Konstantinos G Psilas
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

4.  Mooren'S ulcer in ibadan, southwest Nigeria.

Authors:  O Fasina; Ao Ogundipe; Ei Ezichi
Journal:  J West Afr Coll Surg       Date:  2013 Jul-Sep

5.  Immunosuppressives in Peripheral Ulcerative Keratitis.

Authors:  K Shyamsundar; J Biswas; K Narayanan
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Bilateral, anterior stromal ring opacity of the cornea.

Authors:  G R Melles; J P de Séra; C A Eggink; J R Cruysberg; P S Binder
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

7.  The involvement of multipotential progenitor cells in Mooren's ulcer.

Authors:  In Gul Lee; Juan Ye; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

8.  Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion.

Authors:  Ashok Kumar; Jing Zhang; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

9.  Punctate keratopathy of West Indians in patients undergoing photorefractive surgery.

Authors:  Virgilio Galvis; Alejandro Tello; Mario L Revelo; David Paredes; Luis Carlos Jaramillo
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 10.  Scleritis and peripheral ulcerative keratitis.

Authors:  Anat Galor; Jennifer E Thorne
Journal:  Rheum Dis Clin North Am       Date:  2007-11       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.